PeterLabs Holdings Bhd
KLSE:PLABS
Net Margin
PeterLabs Holdings Bhd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
MY |
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
81.2m MYR |
2%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
834.7B USD |
24%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
-4%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
373.1B USD |
24%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
35%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
211.3B CHF |
14%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
189B CHF |
23%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
163.6B GBP |
13%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
210.3B USD |
27%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
-126%
|
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
116.9B EUR |
14%
|
PeterLabs Holdings Bhd
Glance View
PeterLabs Holdings Bhd.is an investment company, which engages in the manufacture, distribution and trading of animal health and nutrition products. The company is headquartered in Nilai, Negeri Sembilan. The company went IPO on 2011-07-26. The firm is engaged in the manufacturing, distribution and trading of animal health and nutrition products. Its segments include Manufacturing and Trading. The Manufacturing segment is engaged in the manufacturing of animal health and nutrition products. The Trading segment is engaged in the trading and distribution of animal health and nutrition products. Its products include biosecurity and disinfectant, compound feed supplement, feed additives, nutritional premix, pharmaceutical and water-soluble supplement. The firm provides technical information exchange with its customer’s supervisors, technicians and in-house veterinarians, livestock information sharing, post-mortem on diseased animals, blood sampling of diseased animals for testing and individualize latest technologies in the manufacture of feed additives for feed and farming industry.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on PeterLabs Holdings Bhd's most recent financial statements, the company has Net Margin of 1.6%.